Lovir (200mg/90 tablet)

LOVIR tablets contain the active ingredient aciclovir. Aciclovir belongs to a group of medicines called 'anti-virals'. LOVIR works by stopping the herpes virus being able to reproduce. The length and severity of an outbreak of herpes is therefore reduced. Long term use of LOVIR can reduce the number of herpes outbreaks in people who experience this condition often. LOVIR does not get rid of the herpes virus from body. LOVIR Dispersible tablets are indicated for: Treatment of Herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes, Suppression (prevention of recurrences) of recurrent Herpes simplex infections in immune-competent patients, Prophylaxis of Herpes simplex infections in immune-compromised patients, Treatment of acute Herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster-associated pain and for the reduction of the incidence and duration of post-herpetic neuralgia, Management of patients with severe AIDS who have a CD4 count of less than 50/µL. Studies have shown that oral aciclovir given in conjunction with anti-retroviral therapy reduced mortality in patients with advanced HIV disease. Storage: Store at or below 25 °C. Protect from light & moisture. The shelf life of the tablets in their original packaging is 36 months. Presentation: White to off-white capsule shaped, biconvex uncoated tablet with “200” embossed on one side and “ACV” on the other side. Pack quantities: blister packs of 90 tablets.